This author has not written his bio yet.
But we are proud to say that Melanie Piontek contributed 41 entries already.
Langenfeld, Germany – ARTES Biotechnology, the German-based biopharmaceutical CDMO for microbial cell lines and process development, will exhibit at the world’s premier biotechnology event, the BIO International Convention, this time in June in Boston, USA. ARTES will be part of the German Pavilion at Location #3065 at the Boston Convention & Exhibition Center. CDMO […]
Langenfeld, Germany: – ARTES Biotechnology, the German-based biopharmaceutical CDMO specializing in development of microbial cell lines for recombinant proteins and vaccines, is returning to participate in Europe’s leading life sciences partnering conference, BIO-Europe 2024, this year in Stockholm for its 30th Anniversary. ARTES will have an exhibition booth at the conference (149) at the Stockholmsmässan […]
Geleen – Langenfeld, May 2024 ARTES Biotechnology and Basic Pharma are almost there! The companies are nearing completion of their joint project with the production of recombinant Human Serum Albumin (rHSA) and the first vials are expected to be available this summer. ARTES, a leading company that specialized in developing and transferring recombinant cell lines […]
Langenfeld, Germany; 10th of January 2024 ARTES Biotechnology GmbH announced today that Volker Jenzelewski reinforces the executive board of ARTES as Managing Director beginning of the year. He will manage the company in close cooperation with Dr. Michael Piontek, Managing Director and founder of ARTES Biotechnology and with Dr. Melanie Piontek, Business Development Director. Volker […]
ARTES Biotechnology and Basic Pharma join in a strategic Collaboration and Co-Marketing Partnership for Pharmaceutical Recombinant Protein Production Geleen – Langenfeld, October 2023 ARTES Biotechnology, a leading company specializing in development and transfer of recombinant cell lines and protein production processes from microbial expression systems and Basic Pharma, a pharmaceutical company focusing on niche […]
